FDA Inspection 976058 — PolyPeptide Laboratories (Sweden) AB
The FDA completed an inspection of PolyPeptide Laboratories (Sweden) AB on May 27, 2016 in Limhamn. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 27, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Limhamn (Sweden)